Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth...

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader

"Adds high-growth commercial franchise to Neuroscience portfolio with Epidiolex®, the first and only FDA-approved prescription cannabidiol medicine and a potential near-term blockbuster

Enhanced product diversification of combined company expected to provide accelerated double-digit revenue growth

Anticipated to be accretive in first full year of combined operations and substantially accretive thereafter..."

020321 GW Pharma News - Google Docs

.pdf

Download PDF • 95KB